Study Group: Physicians who Treat Uveitis (US)(?)
Council Members in this Study Group: 38
Request a survey with this Study Group
Leading Experts in this Study Group
Sanjay Rao, MDMedical Director
Lakeside Eye Clinic
Sanjay Rao, MD, is the Medical Director and Director of Cornea and Refractive Surgery at the Lakeside Eye Clinic in Chicago. He was previously the Director of Cornea and Refractive Surgery at the University of Chicago. He has clinical expertise in diseases of the cornea and is a high volume cataract,...
Barry Schechter, MDDirector of Corneal and External Diseases
Florida Eye Microsurgical Institute, Inc.
Barry Schechter, MD, is the Director of Department of Cornea and External Disease at Florida Eye Microsurgical Institute. Dr. Schechter's practice involves diseases of the ocular surface including dry eyes, allergies, infection; the latest in corneal, refractive, and cataract surgery, and glaucoma....
Eric Donnenfeld, MDCo-Chairman of Cornea
Nassau University Medical Center
Eric Donnenfeld, MD, is a Clinical Professor of Ophthalmology at New York University and Trustee at Dartmouth Medical School. He is Co-Chairman of Cornea at Nassau University Medical Center. He is also the Surgical Director of Lions Eye Bank for Long Island, the National Medical Director for TLC Laser...
Ophthalmologist
Pacific Eye Associates
Anne Fung, MD, is an Ophthalmologist specializing in Medical Retina at California Pacific Medical Center and Pacific Eye Associates in San Francisco. She has expertise in macular degeneration and has worked primarily with medical therapies for neovascular macular degeneration including Lucentis and...
Related Study Groups
| Study Group Name | Members |
|---|---|
| Ophthalmologists (US) | 1070 |
| Ophthalmologists | 1536 |
| Physicians who Treat Dry Eye (US) | 127 |
| Ophthalmologists who Treat Macular Degeneration (US) | 169 |
| Corneal and Refractive Ophthalmic Surgeons (US) | 502 |
| Patanol Prescribers: Ophthalmologists (US) | 47 |
| Vitreoretinal Surgeons (US) | 164 |
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
With the recent trends of presbyopic correction , Bausch and Lomb has now entered the arena.
The market for eye drops for the treatment of open angle glaucoma is huge. Profit potential for pharmaceutical companies, however, is limited by the time period that they are afforded patent protection. Combigan, the just approved brimonidine/timolol combination therapy, affords Allergan new patent...
Alacrity Biosciences has completed a Phase 2 clinical trial of ALTY-1501, an eye drop for the treatment of dry eye. Dry eye (or keratoconjunctivitis sicca (KCS) affects more than 10% of the US population and its incidence is increasing as baby boomers become senior citizens. Although the small...
Genentech has had first year revenues of $800 million from its drug Lucentis, which is used intravitreaaly to treat macular degeneration on label and some other conditions off label. Although this amount of sales places Lucentis well within the blockbuster...
Innovative Preventive Pulmonary Therapy Offers Promise of Increased Longevity for Young Cystic Fibrosis Patients
Inspire Pharmaceuticals' founding concept is based upon P2Y2 receptor agonist technology, now approaching fruition with groundbreaking cystic fibrosis (CF) clinicals. Well tolerated three times daily nebulizer therapy with denufosol for young CF patients promises improved pulmonary function,...
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Non-Academic Community Hospital or Clinic
Most Common Job Types:
- Physician - Attending Physician
- Physician - Director
- Partner
- Owner
- President
- Physician - Division Head
- Optometrist